Literature DB >> 18242658

Effects of cellular differentiation, chromosomal integration and 5-aza-2'-deoxycytidine treatment on human papillomavirus-16 DNA methylation in cultured cell lines.

Mina Kalantari1, Denis Lee, Itzel E Calleja-Macias, Paul F Lambert, Hans-Ulrich Bernard.   

Abstract

Human papillomavirus-16 (HPV-16) genomes in cell culture and in situ are affected by polymorphic methylation patterns, which can repress the viral transcription. In order to understand some of the underlying mechanisms, we investigated changes of the methylation of HPV-16 DNA in cell cultures in response to cellular differentiation, to recombination with cellular DNA, and to an inhibitor of methylation. Undifferentiated W12E cells, derived from a precancerous lesion, contained extrachromosomal HPV-16 DNA with a sporadically methylated enhancer-promoter segment. Upon W12E cell differentiation, the viral DNA was demethylated, suggesting a link between differentiation and the epigenetic state of HPV-16 DNA. The viral genomes present in two W12I clones, in which individual copies of the HPV-16 genome have integrated into cellular DNA (type 1 integrants), were unmethylated, akin to that seen in the cervical carcinoma cell line SiHa (also a type 1 integrant). This finding is consistent with hypomethylation being necessary for continued viral gene expression. In contrast, two of three type 2 integrant W12I clones, containing concatemers of HPV-16 genomes integrated into the cellular DNA contained hypermethylated viral DNA, as observed in the cervical carcinoma cell line CaSki (also a type 2 integrant). A third, type 2, W12I clone, interestingly with fewer copies of the viral genome, contained unmethylated HPV-16 genomes. Epithelial differentiation of W12I clones did not lead to demethylation of chromosomally integrated viral genomes as was seen for extrachromosomal HPV-16 DNA in W12E clones. Hypomethylation of CaSki cells in the presence of the DNA methylation inhibitor 5-aza-2'-deoxycytidine reduced the cellular viability, possibly as a consequence of toxic effects of an excess of HPV-16 gene products. Our data support a model wherein (i) the DNA methylation state of extrachromosomal HPV16 replicons and epithelial differentiation are inversely coupled during the viral life cycle, (ii) integration of the viral genome into the host chromosome events leads to an alteration in methylation patterns on the viral genome that is dependent upon the type of integration event and possibly copy number, and (iii) integration universally results in the viral DNA becoming refractory to changes in methylation state upon cellular differentiation that are observed with extrachromosomal HPV-16 genomes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18242658      PMCID: PMC2556224          DOI: 10.1016/j.virol.2007.12.016

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  48 in total

Review 1.  The role of DNA methylation in modulating Epstein-Barr virus gene expression.

Authors:  K D Robertson
Journal:  Curr Top Microbiol Immunol       Date:  2000       Impact factor: 4.291

Review 2.  DNA methylation patterns and epigenetic memory.

Authors:  Adrian Bird
Journal:  Genes Dev       Date:  2002-01-01       Impact factor: 11.361

3.  Detection of integrated papillomavirus sequences by ligation-mediated PCR (DIPS-PCR) and molecular characterization in cervical cancer cells.

Authors:  F Luft; R Klaes; M Nees; M Dürst; V Heilmann; P Melsheimer; M von Knebel Doeberitz
Journal:  Int J Cancer       Date:  2001-04-01       Impact factor: 7.396

4.  High-throughput detection of human papillomavirus-18 L1 gene methylation, a candidate biomarker for the progression of cervical neoplasia.

Authors:  Tolga Turan; Mina Kalantari; Kate Cuschieri; Heather A Cubie; Hanne Skomedal; Hans-Ulrich Bernard
Journal:  Virology       Date:  2006-12-18       Impact factor: 3.616

5.  Differentiation-dependent chromatin rearrangement coincides with activation of human papillomavirus type 31 late gene expression.

Authors:  L M del Mar Peña; L A Laimins
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

6.  Targeted recruitment of a histone H4-specific methyltransferase by the transcription factor YY1.

Authors:  Natalie Rezai-Zadeh; Xiaohong Zhang; Fares Namour; Gyorgy Fejer; Yu-Der Wen; Ya-Li Yao; Ildiko Gyory; Kenneth Wright; Edward Seto
Journal:  Genes Dev       Date:  2003-04-15       Impact factor: 11.361

7.  The fate of foreign DNA in mammalian cells and organisms.

Authors:  W Doerfler; R Remus; K Müller; H Heller; U Hohlweg; R Schubbert
Journal:  Dev Biol (Basel)       Date:  2001

Review 8.  Gene expression of genital human papillomaviruses and considerations on potential antiviral approaches.

Authors:  Hans-Ulrich Bernard
Journal:  Antivir Ther       Date:  2002-12

9.  CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression.

Authors:  Vinay Badal; Linda S H Chuang; Eileen Hwee-Hong Tan; Sushma Badal; Luisa L Villa; Cosette M Wheeler; Benjamin F L Li; Hans-Ulrich Bernard
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

10.  Methylation patterns of papillomavirus DNA, its influence on E2 function, and implications in viral infection.

Authors:  Kitai Kim; Peggy A Garner-Hamrick; Chris Fisher; Denis Lee; Paul F Lambert
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

View more
  22 in total

1.  Epigenetics of human papillomaviruses.

Authors:  Eric Johannsen; Paul F Lambert
Journal:  Virology       Date:  2013-08-13       Impact factor: 3.616

2.  Methylation of human papillomavirus 16, 18, 31, and 45 L2 and L1 genes and the cellular DAPK gene: Considerations for use as biomarkers of the progression of cervical neoplasia.

Authors:  Mina Kalantari; Kathryn Osann; Itzel E Calleja-Macias; Seong Kim; Bing Yan; Sara Jordan; Dana M Chase; Krishnansu S Tewari; Hans-Ulrich Bernard
Journal:  Virology       Date:  2013-11-09       Impact factor: 3.616

3.  Distinct human papillomavirus type 16 methylomes in cervical cells at different stages of premalignancy.

Authors:  Janet L Brandsma; Ying Sun; Paul M Lizardi; David P Tuck; Daniel Zelterman; G Kenneth Haines; Maritza Martel; Malini Harigopal; Kevin Schofield; Matthew Neapolitano
Journal:  Virology       Date:  2009-05-13       Impact factor: 3.616

4.  Laser capture microdissection of cervical human papillomavirus infections: copy number of the virus in cancerous and normal tissue and heterogeneous DNA methylation.

Authors:  Mina Kalantari; Alejandro Garcia-Carranca; Claudia Dalia Morales-Vazquez; Rosemary Zuna; Delia Perez Montiel; Itzel E Calleja-Macias; Bo Johansson; Sonia Andersson; Hans-Ulrich Bernard
Journal:  Virology       Date:  2009-06-04       Impact factor: 3.616

5.  CpG methylation in human papillomavirus (HPV) type 31 long control region (LCR) in cervical infections associated with cytological abnormalities.

Authors:  Brigitta László; Annamária Ferenczi; László Madar; Eszter Gyöngyösi; Anita Szalmás; Levente Szakács; György Veress; József Kónya
Journal:  Virus Genes       Date:  2016-04-20       Impact factor: 2.332

6.  Human papillomavirus-16 and -18 in penile carcinomas: DNA methylation, chromosomal recombination and genomic variation.

Authors:  Mina Kalantari; Luisa L Villa; Itzel E Calleja-Macias; Hans-Ulrich Bernard
Journal:  Int J Cancer       Date:  2008-10-15       Impact factor: 7.396

Review 7.  The papillomavirus E2 proteins.

Authors:  Alison A McBride
Journal:  Virology       Date:  2013-07-10       Impact factor: 3.616

8.  APOBEC3 deaminases induce hypermutation in human papillomavirus 16 DNA upon beta interferon stimulation.

Authors:  Zhe Wang; Kousho Wakae; Kouichi Kitamura; Satoru Aoyama; Guangyan Liu; Miki Koura; Ahasan M Monjurul; Iwao Kukimoto; Masamichi Muramatsu
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

9.  Some novel insights on HPV16 related cervical cancer pathogenesis based on analyses of LCR methylation, viral load, E7 and E2/E4 expressions.

Authors:  Damayanti Das Ghosh; Bornali Bhattacharjee; Shrinka Sen; Laikangbam Premi; Indranil Mukhopadhyay; Rahul Roy Chowdhury; Sudipta Roy; Sharmila Sengupta
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

10.  Aberrant promoter methylation and expression of UTF1 during cervical carcinogenesis.

Authors:  Samuel Guenin; Mustapha Mouallif; Rachel Deplus; Xavier Lampe; Nathalie Krusy; Emilie Calonne; Katty Delbecque; Frederic Kridelka; François Fuks; My Mustapha Ennaji; Philippe Delvenne
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.